Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
Background: Gestational alloimmune liver disease (GALD) is a rare but critical cause of neonatal liver failure. After discovering the maternal-fetal alloimmune mechanism, intravenous immunoglobulin (IVIG) with or without exchange transfusion (ET) has gradually replaced antioxidant cocktails as the f...
Saved in:
Main Authors: | Pai-Jui Yeh (Author), Shiu-Feng Huang (Author), Ming-Chou Chiang (Author), Chao-Jan Wang (Author), Ming-Wei Lai (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neonatal hemochromatosis attributed to gestational alloimmune liver disease treated with intravenous immunoglobulin and exchange transfusion therapy: an evidence-based case report
by: Adhi Teguh Perma Iskandar, et al.
Published: (2021) -
Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report
by: Minhazur Sarker, et al.
Published: (2022) -
Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion
by: Emel Okulu, et al.
Published: (2022) -
Drug-induced Liver Injury from Intravenous Immunoglobulin for Prevention of Recurrent Gestational Alloimmune Liver Disease: A Clinical Catch-22
by: Jessica A. Meyer, et al.
Published: (2024) -
Double-Filtration Plasmapheresis and High-Dose Intravenous Immunoglobulin Therapy in a Case of Anti-M Alloimmunization
by: Shun Yasuda, et al.
Published: (2024)